Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madison Covered Call & Equity Income Fund Class R6 (MENRX)

9.39
Net Asset Value
-0.32%
1 Day
+3.87%
Year-to-Date
Overall Morningstar Rating
Option writing
Style or Category
No Load
Sales Expenses
0.90%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide consistent total return and, secondarily, to provide a high level of income and gains from option premiums. The fund invests, under normal conditions, primarily in common stocks of large- and mid-capitalization issuers that are, in the view of the fund's investment adviser, selling at a reasonable price in relation to their long-term earnings growth rates. It will invest at least 80% of its net assets in common stocks, with at least 65% of this amount invested in common stocks of large capitalization issuers that meet the fund's selection criteria.

Performance

1 month-1.16% 3 years+5.52%
3 months+2.29% 5 years--
1 year+8.91% Since inception+7.60%
Data through --

Peer Comparisonvs. Option writing

 MENRXCategory
Performance 5-yr return--+4.56%
Expense ratio0.90%1.48%
Risk 5 year sharpe ratio0.900.83
Net assets$102.7M$295.3M
Average market cap$51.5B$95.0B
Average P/E18.820.4
Portfolio turnover107%107%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyMadison Funds
Fund manager & tenureRay DiBernardo / 6 Years
Minimal initial investment$500,000.00
Minimum IRA investment--

Holdings

U.S. stock65.84%
Cash30.59%
Fixed income1.93%
International stock1.64%
Other0.00%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AAPL Apple2.88%
SPY SPDR® S&P 500 ETF2.68%
CBS CBS2.39%
ESRX Express Scripts Holding Co2.32%
V Visa2.23%
KMX Carmax Inc2.19%
ORCL Oracle2.17%
TROW T. Rowe Price Group Inc2.16%
BIIB Biogen2.14%
CVS CVS Caremark2.11%